Table 2.
Sl No | Macromolecule/Protein Target | Ligand/Small Molecule | Number of Hydrogen Bonds | H-Bond Forming Amino Acid Residues | ∆G (Kcal/mol) |
---|---|---|---|---|---|
1 | 2H6T | Drug | 4 | SER-13, ASP-86, ASP-120 and GLN-121 | −7.5 |
BQ-01 | 3 | THR-221 and THR-222 | −6.5 | ||
BQ-03 | 6 | THR-221, THR-222 and GLY-220 | −7.4 | ||
BQ-05 | 5 | THR-221, THR-222 and GLY-220 | −7.2 | ||
BQ-07 | 6 | THR-221, THR-222 and VAL-12 | −6.8 | ||
2 | 3N9K | Drug | 3 | ASP-145, LEU-304 and ASN-305 | −7.8 |
BQ-01 | 2 | PHE-144 and ASN-146 | −9.4 | ||
BQ-03 | 2 | ASN-146 | −9.7 | ||
BQ-05 | 3 | ASN-146 and TYR-317 | −9.4 | ||
BQ-07 | 2 | ASN-146 | −9.2 | ||
3 | 5TZ1 | Drug | 4 | TYR-132, PHE-463 and ARG-469 | −7.2 |
BQ-01 | 2 | TYR-132 | −8.9 | ||
BQ-03 | 2 | TYR-132 | −8.1 | ||
BQ-05 | 1 | TYR-132 | −8.6 | ||
BQ-07 | 2 | TYR-132 | −8.7 |